• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

BIO Protocol and NuDAO Join Forces to Accelerate Decentralized Science Development

user avatar

by Giorgi Kostiuk

a year ago


BIO Protocol and NuDAO have entered into a partnership aimed at strengthening the decentralized science ecosystem through strategic resource allocation and collaboration.

A Transformative Partnership

A recent press release announced NuDAO's strategic allocation of 6.9% of its treasury to BIO Protocol, highlighting a long-term collaboration to accelerate the decentralized science ecosystem. This partnership combines NuDAO's technological expertise in biotech and AI with BIO Protocol's established DeSci infrastructure.

This strategic partnership demonstrates our confidence in BIO Protocol’s vision and our shared commitment to advancing decentralized science.NuDAO

Key Elements of the Partnership

The partnership includes scientific and technical collaborations: * Joint Development: NuDAO and BIO Protocol will collaborate on significant scientific research initiatives, focusing on IP and NFT development. * Co-Incubation Projects: Both organizations will incubate promising research projects together, providing shared resources and expertise. * Governance: Both entities will actively participate in each other's governance frameworks, promoting collaboration and shared decision-making in DeSci development.

The Role of the CRISPR Token

A key component of the partnership is the integration of NuDAO's CRISPR token, which powers the research ecosystem. CRISPR will gain access to BIO Protocol’s research resources, driving innovation. CRISPR token holders will have the opportunity to participate in key decisions, influencing the future of decentralized science. The collaboration will enhance CRISPR’s position within the broader DeSci network, unlocking opportunities for growth and innovation.

The partnership aims to create a global decentralized research community enabling borderless collaboration. It supports the commercialization of biotech innovations, such as rare disease research and longevity research.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Risks in the AI Market Amidst Stock Surge

chest

Experts warn of potential risks in the AI stock market, drawing parallels to the late 1990s dot-com bubble.

user avatarSatoshi Nakamura

Amazon's Trainium Chips Could Challenge Nvidia

chest

Amazon is developing its own Trainium chips to compete with Nvidia's GPUs, potentially reshaping the AI chip market.

user avatarNguyen Van Long

CoinShares Unveils The Silent Portfolio Report

chest

CoinShares has recently released a new report titled The Silent Portfolio, which focuses on cryptocurrency investment strategies.

user avatarJesper Sørensen

BitGo Announces Workforce Reduction Amid Shift to AI

chest

BitGo is reducing its workforce by nearly 15% to focus on AI and enhanced financial services.

user avatarRajesh Kumar

Michael Saylor's Strategy Faces Significant Unrealized Losses

chest

Michael Saylor's Strategy is facing a significant unrealized loss of $14 billion due to a decline in Bitcoin prices.

user avatarLucas Weissmann

Jiang Zhuoer Predicts Bitcoin Bear Market Bottom in Late 2026

chest

Chinese mining figure Jiang Zhuoer predicts that Bitcoin may not find its final bear market bottom until late 2026, estimating a range of $42,000 to $44,000.

user avatarFilippo Romano

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.